A detailed history of Kingsbury Capital Investment Advisors LLC transactions in Corbus Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Kingsbury Capital Investment Advisors LLC holds 33,700 shares of CRBP stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,700
Holding current value
$1.52 Million
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

BUY
$0.17 - $0.3 $5,729 - $10,110
33,700 New
33,700 $6,000
Q2 2022

Aug 09, 2022

SELL
$0.21 - $0.53 $7,098 - $17,914
-33,800 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$0.32 - $0.67 $10,816 - $22,646
33,800 New
33,800 $18,000

Others Institutions Holding CRBP

About Corbus Pharmaceuticals Holdings, Inc.


  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $5.67B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Kingsbury Capital Investment Advisors LLC Portfolio

Follow Kingsbury Capital Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kingsbury Capital Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kingsbury Capital Investment Advisors LLC with notifications on news.